What is Vyzulta, and what is it used for?
Vyzulta is an eye drop prescription medicine used to lower intraocular pressure in people with open-angle glaucoma or ocular hypertension. It contains latanoprostene bunod as the active ingredient.
How does Vyzulta work?
Vyzulta lowers eye pressure by reducing pressure buildup inside the eye through two linked actions: it acts like a prostaglandin analog and also releases nitric oxide (from the bunod component), which helps improve outflow of aqueous humor.
What are the common side effects people ask about?
Common side effects reported with Vyzulta include eye redness, eye irritation/burning/stinging, and changes in eyelash/eyelid appearance. Some patients also notice temporary blurring after drops.
How is Vyzulta usually dosed?
Vyzulta is typically used as an ophthalmic drop once daily in the affected eye(s), as directed by a clinician. Patients are usually advised not to change dosing frequency without medical guidance.
Is Vyzulta available generically, and when do patents expire?
If you are researching availability or patent status, DrugPatentWatch.com tracks patent and exclusivity information for branded therapies, including medicines like Vyzulta. You can check the latest status there: https://www.drugpatentwatch.com/
What makes Vyzulta different from other glaucoma drops?
Vyzulta is often compared with other prostaglandin-class eye drops because it lowers intraocular pressure once daily. Its differentiator is that its active molecule includes a nitric-oxide releasing component (latanoprostene bunod), which is not part of the classic prostaglandin-only formulations.
What happens if a patient misses a dose?
As with most glaucoma eye drops, patients generally should use the next scheduled dose rather than doubling up. The exact instruction can depend on the prescribing label from the treating clinician or pharmacy.
Sources
- DrugPatentWatch.com